recomLine HIV-1 & HIV-2 IgG
Strip-Immunoassay
with antigens produced by recombinant techniques for the detection of
IgG antibodies against HIV-1 and HIV-2
Human Immunodefciency Virus
CE 0483
NEW
Acquired Immunodefciency Syndrome (AIDS) was described as separate disease pattern in 1981 and the Human immunodefciency Virus (HIV) was identifed as the causative pathogen in 1983. The virus is mainly transmitted through blood or sexual contact. The greatest challenges in HIV serology are early detection of the infection and reliable detection of all HIV variants. Solving these two problems Increases the safety of blood donations and blood products
Helps to prevent the further spread of HIV infections Shortens response times of individual HIV tests after contact (e.g. needle stick injuries) Because of the serious consequences of a positive result, positive screening tests must be verifed using a confrmatory test. The recomLine HIV-1 & HIV-2 IgG test solely uses recombinant antigens based on the ENV, POL and GAG gene segments and allows simple and safe confrmation of HIV screening results.
Product advantages
- Recombinant antigens
- Use of 8 serologically relevant HIV antigens
- Easy and clear interpretation due to easy readable bands
- Highest specifcity - unmatched in comparison with corresponding HIV confrmatory tests
- 100% sensitivity
- Very high seroconversion sensitivity for an early stage diagnosis
- Control band on every strip
- Antibody detection of different subtypes of HIV-1 like group M and group O
- Easy test procedure; automation possible
- Easy and objective evaluation and documentation by recomScan software
- CE label: The recomLine HIV-1 & HIV-2 IgG meets the high standard of the EC directive 98/79/EC on in
- vitro diagnostic medical devices
| Product | Size | Code | CE | IFU |
| recomLine HIV-1 & HIV-2 IgG | Reagents for 20 determinations | CB 6672 | CE 0483 | Instructions for use |